Bioinvent International
IPOUnleashing Immunity to Fight Cancer
- Headquarters
- Lund
- Business Model
- B2B
- Website
- bioinvent.com
About
BioInvent International is a Swedish clinical-stage biotechnology company that discovers and develops novel antibody-based therapeutics for cancer, using its proprietary F.I.R.S.T™ screening platform and n-CoDeR® antibody library. The company has ongoing collaborations with global pharmaceutical partners including CASI, Merck, Daiichi, and Mitsubishi Tanabe, and also provides contract antibody manufacturing services through BioInvent Manufacturing, active since 1988.
Summary
Bioinvent International is a Biotech company based in Lund, Sweden. Investors include Pfizer Ventures and HBM Healthcare Investments.
Funding History
Jul 2022
Sign up to see all 5 rounds
IPO through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bioinvent-international"><img src="https://indexed.vc/api/badge/company/bioinvent-international" alt="Bioinvent International on Indexed.vc" width="260" height="76" /></a>